Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people feel fine after their first Wegovy shot. Some notice mild nausea within a few hours; a smaller number feel nothing unusual at all. The 0.25 mg starting dose is deliberately low — its job is to let your system adjust gradually, not to produce dramatic weight-loss effects on day one. Wegovy (semaglutide) is a prescription-only medicine, and how your body responds in those first days is something a prescriber considers carefully before and after you start. The NHS medicines page on semaglutide gives a clear overview of what is normal and what warrants attention.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the scene: you've done your first injection (abdomen, thigh, or upper arm) and you're going about your afternoon wondering when, or whether, you'll feel anything. For a lot of people, the answer is: not much. The 0.25 mg starting dose is low enough that many people reach bedtime without any notable sensation beyond mild awareness at the injection site.
Some people do notice nausea within two to four hours. It tends to feel like a general queasiness rather than sharp stomach pain, the kind that makes you less interested in your next meal, which is in fact part of how semaglutide works. As a GLP-1 receptor agonist, it slows how quickly the stomach empties and amplifies fullness signals to the brain. That mechanism, helpful over weeks and months, can feel unsettling on day one.
Fatigue is another early visitor for some, a heaviness that arrives in the afternoon and lifts by the next morning. Headache crops up occasionally. These are signs the medicine is doing something, not signs that something has gone wrong. Injection-site redness or a small bump at the site is common and usually fades within hours. If you want to read further about the first day specifically, our page on the first day of Wegovy covers the timeline in more detail.
A question our prescribers hear most weeks is some version of: "I felt rough yesterday, does it stay like this?" The honest answer is that for most people, day two is noticeably better than the afternoon of injection day. Nausea from the first shot often peaks within the first twelve hours and then retreats.
What can linger is a reduced appetite. You might find breakfast less appealing than usual, or notice you reach fullness faster at lunch. That is the medicine working as intended. It is worth eating anyway, smaller portions of protein-rich food help maintain muscle and keep energy stable. Staying well hydrated matters more than usual, because dehydration amplifies nausea.
Some people feel completely normal the day after and worry they have done something wrong. They haven't. Individual responses at 0.25 mg vary considerably, and the absence of side effects at the starting dose is not a reason to escalate faster. The titration schedule exists for a reason, and your prescriber sets the pace. For a closer look at what the day after specifically can involve, the page on the day after your Wegovy shot is worth reading.
Less commonly, people report sneezing or nasal symptoms, an odd pairing with a weight-loss medicine, but one that has been reported. If that's your experience, you're not alone; our page on Wegovy and sneezing covers what's known.
The gastrointestinal effects above are expected and manageable. A smaller number of side effects warrant prompt attention. The one that matters most is severe, persistent stomach pain (especially pain that reaches into the back) with or without vomiting. This can be a sign of pancreatitis, a known but uncommon risk with GLP-1 medicines. The MHRA reinforced this in a Drug Safety Update in January 2026, which noted that acute pancreatitis requires urgent medical assessment. Do not wait to see if it settles.
Signs of an allergic reaction (swelling of the face or throat, difficulty breathing, a rapid heartbeat) also need immediate attention. Symptoms of dehydration from prolonged vomiting or diarrhoea (dizziness when standing, very dark urine, not urinating) are a reason to seek help rather than push through. These are not common experiences after a first 0.25 mg shot, but knowing the line between "normal adjustment" and "needs medical attention" is genuinely useful.
If you have concerns about a side effect, your prescriber is the right first call. Suspected adverse reactions can also be reported directly through the MHRA Yellow Card scheme, a step that contributes to the ongoing safety monitoring of medicines like semaglutide.
The first shot is rarely the most informative. Most people find that their response shifts meaningfully as doses increase. Nausea that was noticeable at 0.5 mg often settles before the move to 1.0 mg. Each step up can bring a brief return of GI symptoms, which then ease again. It follows a pattern, and knowing the pattern makes it far less alarming.
Appetite suppression tends to become more reliable and consistent from the 1.0 mg or 1.7 mg stage onwards. The overall experience of being on Wegovy, weeks in, is described by many people as a quietening of food noise rather than anything dramatic. For a broader picture of how the medicine feels across weeks of treatment, the page on how you feel on Wegovy pulls that longer view together.
Wegovy is a prescription-only medicine, and its place in a treatment plan depends on your full clinical picture, weight, health history, other medicines you take, and your goals. If you are weighing it up or have just started, the Wegovy treatment overview sets out how it works and what the licensed indications cover. For a side-by-side look at what treatment through a private regulated pharmacy actually costs, our Wegovy price comparison page is honest about what is and isn't included in different providers' fees.
If you're ready to discuss starting treatment, or want a prescriber to review how you're responding so far, you can speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.